Propanc Biopharma (PPCB) Cash Flow Statement

0.1080
-0.0043-3.83%

Close Mar 26 16:00 ET

0.1089
+0.0009+0.83%

Post 17:16 ET

1.71MMarket Cap-0.02P/E (TTM)

Propanc Biopharma (PPCB) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Dec 31, 2025

(Q1)Sep 30, 2025

(FY)Jun 30, 2025

(Q4)Jun 30, 2025

(Q3)Mar 31, 2025

(Q2)Dec 31, 2024

(Q1)Sep 30, 2024

(FY)Jun 30, 2024

(Q4)Jun 30, 2024

(Q3)Mar 31, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-5,434.72%-999.14K

-723.33%-1.94M

56.67%-405.17K

89.54%-27.19K

-56.79%-161.2K

107.84%18.73K

29.37%-235.52K

15.39%-935.12K

-46.07%-259.97K

46.66%-102.81K

Net income from continuing operations

-618.62%-3.09M

-1,265.40%-4.84M

-3,136.60%-58.92M

-1,035.45%-4.07M

-10,165.30%-54.07M

26.39%-430.18K

-0.98%-354.31K

31.57%-1.82M

52.06%-358.58K

34.96%-526.7K

Operating gains losses

-791.06%-676.26K

-357.99%-104.01K

3,826.59%1.08M

533.86%171.68K

1,005,632.53%834.59K

-37.38%97.86K

85.42%-22.71K

-96.25%27.54K

-93.60%27.09K

-100.02%-83

Depreciation and amortization

39.24%6.03K

-33.10%3.7K

-6.78%20.19K

-9.18%5.24K

6.56%5.09K

-26.04%4.33K

5.17%5.53K

-5.56%21.66K

3.73%5.76K

-15.09%4.77K

Other non cash items

-3,557.62%-2.98M

5,728.14%3.91M

17,244.08%51.66M

-2,947.24%-1.39M

64,138.76%52.9M

-9.84%86.2K

-5.45%67.03K

-8.71%297.84K

-67.10%48.99K

52.18%82.35K

Change In working capital

-5.42%246.41K

-1,416.65%-907.69K

172.68%1.14M

715.22%640.97K

-50.19%167.78K

196.82%260.53K

-28.91%68.94K

-11.67%417.42K

-1,305.61%-104.18K

67.37%336.85K

-Change in receivables

-954.64%-8.57K

-1,112.35%-3.04K

-3,287.32%-2.41K

-163.78%-1.53K

-9.90%-1.63K

190.44%1K

-290.15%-251

88.36%-71

425.49%2.39K

-226.60%-1.49K

-Change in prepaid assets

417,273.75%333.74K

---362.33K

101.19%1.38K

100.06%67

-98.96%1.39K

-104.90%-80

--0

-5,425.94%-116.21K

-1,859.65%-120.83K

432.96%133.62K

-Change in payables and accrued expense

-135.37%-91.6K

-1,023.10%-551.58K

111.03%1.12M

1,693.48%570.67K

17.05%231.39K

218.27%258.96K

-72.87%59.75K

74.73%531.1K

599.20%31.82K

14.95%197.68K

-Change in other current liabilities

127.33%1.29K

19.81%-4.72K

-0.57%-21.72K

7.92%-5.51K

-16.16%-5.62K

17.98%-4.71K

-16.85%-5.88K

-8.77%-21.6K

-18.75%-5.99K

0.84%-4.84K

-Change in other working capital

115.91%11.55K

-8.72%13.98K

66.08%40.18K

767.48%77.27K

-586.31%-57.75K

-53.98%5.35K

24.78%15.32K

-87.05%24.2K

-219.17%-11.58K

49.75%11.88K

Cash from discontinued investing activities

Operating cash flow

-5,434.72%-999.14K

-723.33%-1.94M

56.67%-405.17K

89.54%-27.19K

-56.79%-161.2K

107.84%18.73K

29.37%-235.52K

15.39%-935.12K

-46.07%-259.97K

46.66%-102.81K

Investing cash flow

Cash flow from continuing investing activities

-2.27K

-2.49K

Net PPE purchase and sale

---2.27K

---2.49K

----

--0

----

Cash from discontinued investing activities

Investing cash flow

---2.27K

---2.49K

----

--0

----

Financing cash flow

Cash flow from continuing financing activities

1,660.62%965.1K

1,071.43%2.53M

-47.90%490.76K

-96.91%7.76K

218.84%212.49K

-79.99%54.82K

-38.43%215.7K

-15.43%941.89K

150.97%250.97K

-75.27%66.64K

Net issuance payments of debt

--0

-458.22%-772.69K

-17.79%755.41K

13.98%272.41K

237.43%187.49K

-70.86%79.82K

-38.43%215.7K

55.67%918.84K

--239K

-41.20%55.56K

Net common stock issuance

--0

--3.31M

--0

-6.69%23.06K

--11.98K

----

Proceeds from stock option exercised by employees

----

--0

----

Net other financing activities

----

---15K

---264.66K

----

Cash from discontinued financing activities

Financing cash flow

1,660.62%965.1K

1,071.43%2.53M

-47.90%490.76K

-96.91%7.76K

218.84%212.49K

-79.99%54.82K

-38.43%215.7K

-15.43%941.89K

150.97%250.97K

-75.27%66.64K

Net cash flow

Beginning cash position

6,403.42%602.74K

-42.67%12.09K

109.86%21.09K

715.81%50.76K

-79.58%14.63K

39.89%9.27K

109.86%21.09K

147.04%10.05K

-93.33%6.22K

192.74%71.65K

Current changes in cash

-149.37%-36.31K

3,053.24%585.21K

1,163.11%85.59K

-116.08%-19.43K

241.82%51.29K

109.86%73.55K

-217.32%-19.82K

-19.98%6.78K

88.47%-8.99K

-147.11%-36.17K

Effect of exchange rate changes

92.38%-5.19K

-32.05%5.44K

-2,319.26%-94.59K

-180.66%-19.24K

48.19%-15.16K

-327.41%-68.18K

139.38%8K

271.30%4.26K

556.90%23.86K

-265.82%-29.26K

End cash Position

3,735.42%561.24K

6,403.42%602.74K

-42.67%12.09K

715.81%50.76K

-79.58%14.63K

39.89%9.27K

109.86%21.09K

-93.33%6.22K

Free cash flow

-5,446.83%-1M

-724.39%-1.94M

56.67%-405.17K

89.54%-27.19K

-56.79%-161.2K

107.84%18.73K

29.37%-235.52K

15.39%-935.12K

-46.07%-259.97K

46.66%-102.81K

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Dec 31, 2025	(Q1)Sep 30, 2025	(FY)Jun 30, 2025	(Q4)Jun 30, 2025	(Q3)Mar 31, 2025	(Q2)Dec 31, 2024	(Q1)Sep 30, 2024	(FY)Jun 30, 2024	(Q4)Jun 30, 2024	(Q3)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-5,434.72%-999.14K	-723.33%-1.94M	56.67%-405.17K	89.54%-27.19K	-56.79%-161.2K	107.84%18.73K	29.37%-235.52K	15.39%-935.12K	-46.07%-259.97K	46.66%-102.81K
Net income from continuing operations	-618.62%-3.09M	-1,265.40%-4.84M	-3,136.60%-58.92M	-1,035.45%-4.07M	-10,165.30%-54.07M	26.39%-430.18K	-0.98%-354.31K	31.57%-1.82M	52.06%-358.58K	34.96%-526.7K
Operating gains losses	-791.06%-676.26K	-357.99%-104.01K	3,826.59%1.08M	533.86%171.68K	1,005,632.53%834.59K	-37.38%97.86K	85.42%-22.71K	-96.25%27.54K	-93.60%27.09K	-100.02%-83
Depreciation and amortization	39.24%6.03K	-33.10%3.7K	-6.78%20.19K	-9.18%5.24K	6.56%5.09K	-26.04%4.33K	5.17%5.53K	-5.56%21.66K	3.73%5.76K	-15.09%4.77K
Other non cash items	-3,557.62%-2.98M	5,728.14%3.91M	17,244.08%51.66M	-2,947.24%-1.39M	64,138.76%52.9M	-9.84%86.2K	-5.45%67.03K	-8.71%297.84K	-67.10%48.99K	52.18%82.35K
Change In working capital	-5.42%246.41K	-1,416.65%-907.69K	172.68%1.14M	715.22%640.97K	-50.19%167.78K	196.82%260.53K	-28.91%68.94K	-11.67%417.42K	-1,305.61%-104.18K	67.37%336.85K
-Change in receivables	-954.64%-8.57K	-1,112.35%-3.04K	-3,287.32%-2.41K	-163.78%-1.53K	-9.90%-1.63K	190.44%1K	-290.15%-251	88.36%-71	425.49%2.39K	-226.60%-1.49K
-Change in prepaid assets	417,273.75%333.74K	---362.33K	101.19%1.38K	100.06%67	-98.96%1.39K	-104.90%-80	--0	-5,425.94%-116.21K	-1,859.65%-120.83K	432.96%133.62K
-Change in payables and accrued expense	-135.37%-91.6K	-1,023.10%-551.58K	111.03%1.12M	1,693.48%570.67K	17.05%231.39K	218.27%258.96K	-72.87%59.75K	74.73%531.1K	599.20%31.82K	14.95%197.68K
-Change in other current liabilities	127.33%1.29K	19.81%-4.72K	-0.57%-21.72K	7.92%-5.51K	-16.16%-5.62K	17.98%-4.71K	-16.85%-5.88K	-8.77%-21.6K	-18.75%-5.99K	0.84%-4.84K
-Change in other working capital	115.91%11.55K	-8.72%13.98K	66.08%40.18K	767.48%77.27K	-586.31%-57.75K	-53.98%5.35K	24.78%15.32K	-87.05%24.2K	-219.17%-11.58K	49.75%11.88K
Cash from discontinued investing activities
Operating cash flow	-5,434.72%-999.14K	-723.33%-1.94M	56.67%-405.17K	89.54%-27.19K	-56.79%-161.2K	107.84%18.73K	29.37%-235.52K	15.39%-935.12K	-46.07%-259.97K	46.66%-102.81K
Investing cash flow
Cash flow from continuing investing activities	-2.27K	-2.49K				0	0
Net PPE purchase and sale	---2.27K	---2.49K	----	----	----	--0	--0	----	----	----
Cash from discontinued investing activities
Investing cash flow	---2.27K	---2.49K	----	----	----	--0	--0	----	----	----
Financing cash flow
Cash flow from continuing financing activities	1,660.62%965.1K	1,071.43%2.53M	-47.90%490.76K	-96.91%7.76K	218.84%212.49K	-79.99%54.82K	-38.43%215.7K	-15.43%941.89K	150.97%250.97K	-75.27%66.64K
Net issuance payments of debt	--0	-458.22%-772.69K	-17.79%755.41K	13.98%272.41K	237.43%187.49K	-70.86%79.82K	-38.43%215.7K	55.67%918.84K	--239K	-41.20%55.56K
Net common stock issuance	--0	--3.31M	--0	--0	--0	--0	--0	-6.69%23.06K	--11.98K	----
Proceeds from stock option exercised by employees	----	----	----	----	----	----	----	--0	--0	----
Net other financing activities	----	---15K	---264.66K	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	1,660.62%965.1K	1,071.43%2.53M	-47.90%490.76K	-96.91%7.76K	218.84%212.49K	-79.99%54.82K	-38.43%215.7K	-15.43%941.89K	150.97%250.97K	-75.27%66.64K
Net cash flow
Beginning cash position	6,403.42%602.74K	-42.67%12.09K	109.86%21.09K	715.81%50.76K	-79.58%14.63K	39.89%9.27K	109.86%21.09K	147.04%10.05K	-93.33%6.22K	192.74%71.65K
Current changes in cash	-149.37%-36.31K	3,053.24%585.21K	1,163.11%85.59K	-116.08%-19.43K	241.82%51.29K	109.86%73.55K	-217.32%-19.82K	-19.98%6.78K	88.47%-8.99K	-147.11%-36.17K
Effect of exchange rate changes	92.38%-5.19K	-32.05%5.44K	-2,319.26%-94.59K	-180.66%-19.24K	48.19%-15.16K	-327.41%-68.18K	139.38%8K	271.30%4.26K	556.90%23.86K	-265.82%-29.26K
End cash Position	3,735.42%561.24K	6,403.42%602.74K	-42.67%12.09K	-42.67%12.09K	715.81%50.76K	-79.58%14.63K	39.89%9.27K	109.86%21.09K	109.86%21.09K	-93.33%6.22K
Free cash flow	-5,446.83%-1M	-724.39%-1.94M	56.67%-405.17K	89.54%-27.19K	-56.79%-161.2K	107.84%18.73K	29.37%-235.52K	15.39%-935.12K	-46.07%-259.97K	46.66%-102.81K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Recently, the prospect of a ceasefire negotiation between the US and Iran has been dominating market sentiment. On March 26 EST, President T Show More

富哥搞钱

Feb 28 17:22

Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.